Background illustration for clinical trials search

Paid Clinical Trials ​Thousand Oaks

Discover 3,033 paid clinical trials in ​Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Los Angeles CA, West Valley City UT, Fort Worth TX
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase1, Recruiting

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Los Angeles CA, Los Alamitos CA, Lancaster CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07499232

Phase3, Recruiting

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

for
Rectal Adenocarcinoma, Stage IIA Rectal Cancer AJCC v8,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06780787

Phase2, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, Glendale CA, Anaheim CA,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

for
Advanced Relapsed or Refractory Germ Cell Tumours,
Location: Los Angeles CA, Houston TX
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07306559

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Los Angeles CA, Duarte CA, Portland OR, Houston TX,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase1, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Los Angeles CA, Pasadena CA, Lancaster CA, Coronado CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase2, Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Los Angeles CA, Cerritos CA, Newport Beach CA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase2, Phase3, Recruiting

Gene Therapy for HER-Positive Cancer (SENTRY-HER2)

for
HER2 Expressing Solid Tumors
Location: Los Angeles CA, Denver CO, Houston TX, Rochester MN,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT07192432

Phase1, Phase2, Recruiting

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

for
Chronic Kidney Disease
Location: San Dimas CA, San Ramon CA, El Paso TX, Spokane WA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT06717698

Phase2, Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Los Angeles CA, Portland OR, Aurora CO, Seattle WA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT07080242

Phase1, Recruiting

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

for
Solid Tumours
Location: Los Angeles CA, Orange CA, Houston TX, St Louis MO,
Sponsor: Orion Corporation, Orion Pharma

Sex: All

Age: 18+

Code: NCT06725758

Phase1, Phase2, Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Los Angeles CA, Duarte CA, Newport Beach CA, Tucson AZ,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Long Beach CA, Eugene OR, Vancouver WA, Lone Tree CO,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: Los Angeles CA, Santa Ana CA, San Diego CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Los Angeles CA, Beverly Hills CA, Orange CA, Irvine CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

for
Noonan Syndrome
Location: Los Angeles CA, Orange CA, Aurora CO, Dallas TX,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06668805

Phase2, Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

for
Coronary Artery Disease
Location: Glendale CA, Dallas TX, Memphis TN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399705

Phase3, Recruiting

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: Duarte CA, Seattle WA, Dallas TX, Houston TX,
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase1, Phase2, Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Los Angeles CA, West Valley City UT, Seattle WA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase2, Recruiting